JPRN-UMIN000023784未知2 期
Hematopietic stem cell transplantation from HLA 2-3 antigen-mismatched family donor using reduced intensity conditioning - haplo-mini
试验速览
- 阶段
- 2 期
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- ot applicable 至 70years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) allergic for drugs used in this protocol 2) active CNS lesion (exclude original disease) 3) active infection 4) when the physician in chief decides the patient is inappropriate for this protocol
研究者
相似试验
招募中
1 期
Hematopoietic stem cell transplantation from HLA fully mismatched family members for post-transplant relapse/rejection (phase I/II trial)hematologic malignancies relapesd/rejected after allogeneic stem cell transplantationJPRN-UMIN000023548Hyogo College of Medicine20
已完成
1 期
Allogeneic stem cell transplantation from HLA completely mismatched family donor for posttransplant relapsehematologic malignancies relapesd after allogeneic stem cell transplantationJPRN-UMIN000008117Hyogo College of Medicine20
招募中
2 期
HLA-haploidentical stem cell transplantation using a low dose ATG and steroidJPRN-UMIN000028845Hyogo College of Medicine100
已完成
1 期
HLA haploidentical stem cell transplantation using myeloablative regimen including ATGhematologic malignanciesJPRN-UMIN000004904Hyogo College of Medicine20
尚未招募
2 期
Allogeneic hematopoietic stem cell transplantation from a two HLA-haplotype-mismatched family donor for post-transplant relapse/rejection: A prospective phase II study with statistical validation for survival benefithematologic malignancies relapsing or with rejection after allogeneic hematopoietic stem cell transplantationJPRN-UMIN000043973Hyogo College of Medicine50